Twenty-one start-ups from across Europe have secured their places at the EIT Health Catapult Final in December.
The finalists represent the most promising European start-ups across biotech, medtech and digital health.
The EIT Health Catapult, currently in its fifth year, is a training and competition programme that boosts the development of European health start-ups by exposing them to leading experts and international investors.
Each team will now pitch their solution to the EIT Health network (one of the largest healthcare communities worldwide including over 150 leading healthcare organisations) at the EIT Health Summit Series.
The seven finalists in each category (Medtech, Biotech and Digital Health) will compete for a podium place and three prizes per category, worth EUR 40 000; EUR 20 000; and EUR 10 000.
Additionally, one of the finalists will win the ‘Alex Casta Audience Award’ and get a unique opportunity to have their logo displayed on the Nasdaq Tower in New York’s Times Square, where it will be seen by millions of people worldwide.
This year, the EIT Health Catapult has also joined forces with leading healthcare players in Europe to further support the most promising start-ups.
Amazon Web Services (AWS), L3S Partnership, Virdis Group, Lallianse and McDermott Will & Emery have all sponsored additional prizes that will provide the winners with their expertise and support.
Congratulations to the finalists. The level of quality has been exceptional and the final will be a fantastic opportunity for these teams to get some well-deserved visibility in front of our community of experts and investors.
Dr. Kurt Höller - Director of Business Creation at EIT Health
The EIT Health Summit Series will see four live sessions take place from 24 November to 3 December. It will host talks from world-leading figures on the future of AI, healthcare entrepreneurship and business development, and the transformation of healthcare delivery, and culminate in the Health Catapult Final and award ceremony.